0001493152-24-042885.txt : 20241029 0001493152-24-042885.hdr.sgml : 20241029 20241029161522 ACCESSION NUMBER: 0001493152-24-042885 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20241029 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241029 DATE AS OF CHANGE: 20241029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTELLIGENT BIO SOLUTIONS INC. CENTRAL INDEX KEY: 0001725430 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 821512711 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39825 FILM NUMBER: 241405904 BUSINESS ADDRESS: STREET 1: 135 W 41ST ST, STREET 2: FLOOR 5 CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-233-6971 MAIL ADDRESS: STREET 1: 135 W 41ST ST, STREET 2: FLOOR 5 CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: GBS Inc. DATE OF NAME CHANGE: 20190919 FORMER COMPANY: FORMER CONFORMED NAME: Glucose Biosensor Systems (Greater China) Holdings, Inc. DATE OF NAME CHANGE: 20171214 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): October 29, 2024

INTELLIGENT BIO SOLUTIONS INC.

(Exact name of registrant as specified in its charter)

Delaware		001-39825		82-1512711
(State of Incorporation)		(Commission File Number)		(IRS employer identification no.)

135 West, 41st Street, 5th Floor, New York, NY 10036

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (646) 828-8258

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		INBS		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On October 29, 2024, Intelligent Bio Solutions Inc. (the “Company”), issued a press release (the “Press Release”) announcing preliminary unaudited revenue results for the fiscal first quarter ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained herein and in the accompanying exhibits shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

No.		Description
99.1		Press release dated October 29, 2024
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 29, 2024
	INTELLIGENT BIO SOLUTIONS INC.

	By:	/s/ Spiro Sakiris
	Name:	Spiro Sakiris
	Title:	Chief Financial Officer

EX-99.1 2 ex99-1.htm

Exhibit 99.1

Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results

Unaudited quarterly revenue increased 10% year-on-year and 20% quarter-on-quarter

Higher-margin, recurring cartridge revenue expected to surpass reader revenue as primary driver

Expanded distribution network in Saudi Arabia

NEW YORK, October 29, 2024 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced preliminary unaudited revenue results for the fiscal first quarter ended September 30, 2024.

The Company expects unaudited revenue of approximately $0.87 million for the three months ended September 30, 2024, representing an increase of 10% year-on-year and 20% quarter-on-quarter.

The Company’s efforts to maximize recurring revenue from the sale of cartridges used in its Intelligent Fingerprinting Drug Screening System are expected to result in cartridges surpassing readers as the primary revenue driver in the future. Cartridges represent a key source of recurring revenue for the business and carry a higher profit margin than readers. As this trend continues, INBS anticipates an increase in gross profit margins, contributing to long-term financial stability and growth.

The Company’s Intelligent Fingerprinting Drug Screening System, which consists of a proprietary portable platform that analyzes fingerprint sweat using single-use cartridges and a portable handheld reader, is designed as a hygienic and cost-effective system that screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis.

“While we are pleased with another quarter of year-on-year and sequential revenue growth, it is important to note that now, with our readers in the market and over 400 active customer accounts, we are beginning to yield the benefits of higher-margin, recurring revenue from the sale of cartridges. This shift shows a growing confidence in the dependability and quality of our products amongst our strong and growing customer base,” said Harry Simeonidis, President and CEO at Intelligent Bio Solutions. “Customer loyalty and advocacy of our products is driving a steady recurring revenue stream and boosting our profit margins.”

Throughout the first fiscal quarter, the Company concentrated on strategic geographical expansion, with global sales expected to increase by 15% year-on-year. The Company grew its distributor network in Saudi Arabia and is committed to broadening its geographical reach to meet rising demands for drug testing solutions that support workplace safety.

The preliminary unaudited revenue results for the fiscal first quarter and the three months ended September 30, 2024, are based on information available to management as of the date of this press release and are, therefore, subject to adjustments based on the Company’s completion of its quarter-end financial close process. The Company expects to disclose financial results for the fiscal first quarter ended September 30, 2024, in its upcoming Quarterly Report on Form 10-Q, expected to be filed with the Securities and Exchange Commission during the week commencing November 4, 2024.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

For more information, visit http://www.ibs.inc/

Forward-Looking Statements

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.’s ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “projects,” “intends,” “potential,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions’ public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

Company Contact:  

Intelligent Bio Solutions Inc. 

info@ibs.inc  

LinkedIn | Twitter 

Investor & Media Contact: 

Valter Pinto, Managing Director 

KCSA Strategic Communications 

PH: (212) 896-1254 

INBS@kcsa.com

EX-101.SCH 3 inbs-20241029.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 inbs-20241029_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 inbs-20241029_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	Oct. 29, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Oct. 29, 2024
Entity File Number	001-39825
Entity Registrant Name	INTELLIGENT BIO SOLUTIONS INC.
Entity Central Index Key	0001725430
Entity Tax Identification Number	82-1512711
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	135 West, 41st Street,
Entity Address, Address Line Two	5th Floor,
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10036
City Area Code	(646)
Local Phone Number	828-8258
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	INBS
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ibs.inc/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm inbs-20241029.xsd inbs-20241029_lab.xml inbs-20241029_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "INBS", "nsuri": "http://ibs.inc/20241029", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "inbs-20241029.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "labelLink": { "local": [ "inbs-20241029_lab.xml" ] }, "presentationLink": { "local": [ "inbs-20241029_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 24 }, "report": { "R1": { "role": "http://ibs.inc/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-10-29", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-10-29", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001493152-24-042885-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-042885-xbrl.zip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end XML 16 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001725430 2024-10-29 2024-10-29 iso4217:USD shares iso4217:USD shares false 0001725430 8-K 2024-10-29 INTELLIGENT BIO SOLUTIONS INC. DE 001-39825 82-1512711 135 West, 41st Street, 5th Floor, New York NY 10036 (646) 828-8258 false false false false Common Stock, $0.01 par value INBS NASDAQ true false